Adjuvant Therapy for Esophageal Squamous Cell Carcinoma

por Sun, Jong-Mu
Publicado 2020

The Effectiveness of Maintenance Pharmacotherapies for Non-Small Cell Lung Cancer

por Ahn, Myung-Ju, Sun, Jong-Mu, Ahn, Jin Sock, Park, Keunchil
Publicado 2012

Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer

por Sun, Jong-Mu, Hwang, Deok Won, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil
Publicado 2013

Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib

por Kim, Youjin, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil, Sun, Jong-Mu
Publicado 2019

Are there any ethnic differences in the efficacy and safety of immune checkpoint inhibitors for treatment of lung cancer?

por Lee, Jiyun, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Publicado 2020

The Role of Brain Radiotherapy before First-Line Afatinib Therapy, Compared to Gefitinib or Erlotinib, in Patients with EGFR-Mutant Non–Small Cell Lung Cancer

por Jung, Hyun Ae, Park, Sehhoon, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Sun, Jong-Mu
Publicado 2023

Real-world clinical evidence of lazertinib use in acquired EGFR T790M mutated non-small cell lung cancer

por Park, Sehhoon, Jung, Hyun Ae, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Sun, Jong-Mu
Publicado 2023

Second primary pleomorphic carcinoma arising from the pneumonectomy cavity of non-small cell lung cancer: A case report

por Lee, Chaiyoung, Jeong, Byeong-Ho, Lee, Kyungjong, Zo, Jae Il, Sun, Jong-Mu, Choi, Yoon-La, Kim, Hojoong
Publicado 2021

Adjuvant chemotherapy in node‐positive patients after esophagectomy for esophageal squamous cell carcinoma

por Jeon, Yeong Jeong, Cho, Jong Ho, Choi, Yong Soo, Shim, Young Mog, Sun, Jong‐Mu, Kim, Hong Kwan
Publicado 2023

EGFR Mutation–Positive Unresectable Stage III Non-Squamous Lung Cancer Is Associated with a High Incidence of Brain Metastasis

por Kim, Hongsik, Park, Sehhoon, Jung, Hyun Ae, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju
Publicado 2023

Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis

por Byeon, Seonggyu, Ham, Jun Soo, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Publicado 2016

Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab

por Eun, Yeonghee, Kim, In Young, Sun, Jong-Mu, Lee, Jeeyun, Cha, Hoon-Suk, Koh, Eun-Mi, Kim, Hyungjin, Lee, Jaejoon
Publicado 2019

Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea

por Lee, Kangkook, Jung, Hyun Ae, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Publicado 2020

Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: Are They Different from Those with Common EGFR Mutations?

por Jung, Hyun Ae, Park, Sehhoon, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil
Publicado 2020

Comprehensive evaluation of the clinical utility of plasma EGFR test in non-small cell lung cancer patients with acquired resistance to first-line EGFR inhibitors

por Kim, Hongsik, Jung, Hyun Ae, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil, Sun, Jong-Mu
Publicado 2021

Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control stu...

por Lee, Ji Hyun, Lee, Ho Yun, Ahn, Myung-Ju, Park, Keunchil, Ahn, Jin Seok, Sun, Jong-Mu, Lee, Kyung Soo
Publicado 2016

Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model

por Ku, Bo Mi, Choi, Moon Ki, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Publicado 2018

Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea

por Kim, Hyera, Kwon, Minsuk, Kim, Binnari, Jung, Hyun Ae, Sun, Jong-Mu, Lee, Se-Hoon, Park, Keunchil, Ahn, Myung-Ju
Publicado 2020

The different central nervous system efficacy among gefitinib, erlotinib and afatinib in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer

por Jung, Hyun Ae, Woo, Sook Young, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil, Sun, Jong-Mu
Publicado 2020

Continuation of Pembrolizumab with Additional Chemotherapy after Progression with PD-1/PD-L1 Inhibitor Monotherapy in Patients with Advanced NSCLC: A Randomized, Placebo-Controlled...

por Jung, Hyun Ae, Park, Sehhoon, Choi, Yoon-La, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Sun, Jong-Mu
Publicado 2022